1 – 20 of 42
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology
(
- Contribution to journal › Article
- 2023
-
Mark
Digital lifestyle treatment improves long-term metabolic control in type 2 diabetes with different effects in pathophysiological and genetic subgroups
(
- Contribution to journal › Article
- 2022
-
Mark
The role of circulating galectin-1 in type 2 diabetes and chronic kidney disease : evidence from cross-sectional, longitudinal and Mendelian randomisation analyses
(
- Contribution to journal › Article
-
Mark
Effect of self-managed lifestyle treatment on glycemic control in patients with type 2 diabetes
(
- Contribution to journal › Article
- 2018
-
Mark
Sulforaphane improves disrupted ER-mitochondria interactions and suppresses exaggerated hepatic glucose production
(
- Contribution to journal › Article
-
Mark
Novel diabetes subgroups – Authors' reply
(
- Contribution to journal › Letter
-
Mark
Novel subgroups of adult-onset diabetes and their association with outcomes : A data-driven cluster analysis of six variables
(
- Contribution to journal › Article
-
Mark
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes article
(
- Contribution to journal › Article
- 2017
-
Mark
Data Descriptor: Sequence data and association statistics from 12,940 type 2 diabetes cases and controls
(
- Contribution to journal › Article
-
Mark
Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Education immigration and income as risk factors for hemoglobin a1c >70 mmol/mol when diagnosed with type 2 diabetes or latent autoimmune diabetes in adult : A population-based cohort study
(
- Contribution to journal › Article
-
Mark
Metabolite profiling of LADA challenges the view of a metabolically distinct subtype
(
- Contribution to journal › Article
-
Mark
Aortic diameter at age 65 in men with newly diagnosed type 2 diabetes
(
- Contribution to journal › Article
-
Mark
A low-frequency inactivating AKT2 variant enriched in the finnish population is associated with fasting insulin levels and type 2 diabetes risk
(
- Contribution to journal › Article
- 2016
-
Mark
Increased expression of the diabetes gene SOX4 reduces insulin secretion by impaired fusion pore expansion
(
- Contribution to journal › Article
-
Mark
The genetic architecture of type 2 diabetes
(
- Contribution to journal › Article
- 2015
-
Mark
Thrombin stimulates insulin secretion via protease-activated receptor-3.
(
- Contribution to journal › Article
-
Mark
Unique and Shared Metabolic Regulation in Clonal β-cells and Primary Islets Derived from Rat Revealed by Metabolomics Analysis.
(
- Contribution to journal › Article
- 2014
-
Mark
Optogenetic control of insulin secretion in intact pancreatic islets with β-cell-specific expression of Channelrhodopsin-2.
(
- Contribution to journal › Article
-
Mark
Can genetics improve precision of therapy in diabetes?
(
- Contribution to journal › Debate/Note/Editorial